Table 2.

Relationship between clinicopathological parameters and tumor multicentricity.

	Tumor multicentricity
	Patients with solitary BCC	Patients with multiple BCC	p
	n (%)
Age group (years)			0.003*
• <40	29 (3.6)	2 (2.5)
• 40-60	193 (23.7)	8 (9.9)
• 61-80	458 (56.2)	47 (58.0)
• ≥81	135 (16.6)	24 (29.6)
Gender (male)	424 (52.0)	53 (65.4)	0.021**
Tumor size (mm)			0.001*
• 1-10	638 (79.0)	52 (65.0)
• 11-20	143 (17.7)	21 (26.3)
• ≥21	27 (3.3)	7 (8.8)
Tumor localization			0.510*
• Scalp	83 (10.2)	12 (14.8)
• Face	583 (71.5)	53 (65.4)
• Neck	17 (2.1)	1 (1.2)
• Trunk	81 (9.9)	11 (13.6)
• Extremities	39 (4.8)	4 (4.9)
• Not mentioned	12 (1.5)	0 (0)
Histological subtype			0.106*
• Nodular	689 (84.5)	60 (74.1)
• Superficial	74 (9.1)	12 (14.8)
• Basosquamous	19 (2.3)	4 (4.9)
• Morpheaform	21 (2.6)	2 (2.5)
• Other subtypes	12 (1.5)	3 (3.7)
Lymphovascular invasion (present)	4 (0.5)	1 (1.2)	0.375**
Perineural invasion (present)	10 (1.2)	2 (2.5)	0.288**
Ulceration (present)	239 (29.4)	17 (21)	0.144**

*One way ANOVA test, ** Chi-square test